Cancer Treatment Facilities Market Size, Share, & Trends Analysis Report By Treatment (Cancer Surgery, Chemotherapy), By Cancer Type (Blood Cancer, Breast Cancer), By Provider, By Region, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 6 Business Days
Cancer Treatment Facilities Market Growth & Trends
The global cancer treatment facilities market size is anticipated t%li%reach USD 78.71 billion by 2030 and is anticipated t%li%grow at a CAGR of 7.75% over the forecast period, according t%li%a new report by Grand View Research, Inc. Key drivers of market growth include increasing patient assistance programs, government initiatives for cancer awareness, and the increasing demand for personalized medicine.
The increasing prevalence of neoplasm, such as breast cancer, among women worldwide makes it a significant area of specialization and investment for healthcare providers. The demand for advanced diagnostic technologies, personalized medicine, and tailored treatment approaches enhances patient outcomes and survival rates and is expected t%li%drive the growth of the segment during the forecast period. For instance, in January 2024, MGM Healthcare launched Clinic B t%li%support and help patients with comprehensive and advanced treatment for all types of breast health problems - ranging from benign lumps and cysts t%li%tumors and reconstruction.
Furthermore, immunotherapy has become an important part of treating some types of cancer in recent years. Immunotherapy is an advanced type of treatment that is growing its presence due t%li%its ability t%li%enhance the immune system's ability t%li%fight cancer by directing it toward cancer-specific targets; this leads t%li%growing strategic initiatives by the service providers t%li%grow its presence in the market, which is expected t%li%drive the growth in the coming years. In January 2023, BioNTech SE collaborated with the UK government t%li%provide clinical trials for modified mRNA immunotherapies for up t%li%10,000 patients by the end of 2030. In addition, it is focused on offering infectious disease vaccines and investment t%li%increase its footprint in the UK market.
Furthermore, several industry players are launching new services t%li%improve their penetration. For instance, in March 2024, Tampa General Hospital commenced the TGH Cancer Institute Phase I Cancer Research Unit at the main campus in Tampa. The aim of this Phase I Cancer Research Unit is t%li%provide cancer patients with access t%li%leading-edge research studies integrated with compassionate and comprehensive care.
Cancer Treatment Facilities Market Report Highlights
Cancer Treatment Facilities Market Growth & Trends
The global cancer treatment facilities market size is anticipated t%li%reach USD 78.71 billion by 2030 and is anticipated t%li%grow at a CAGR of 7.75% over the forecast period, according t%li%a new report by Grand View Research, Inc. Key drivers of market growth include increasing patient assistance programs, government initiatives for cancer awareness, and the increasing demand for personalized medicine.
The increasing prevalence of neoplasm, such as breast cancer, among women worldwide makes it a significant area of specialization and investment for healthcare providers. The demand for advanced diagnostic technologies, personalized medicine, and tailored treatment approaches enhances patient outcomes and survival rates and is expected t%li%drive the growth of the segment during the forecast period. For instance, in January 2024, MGM Healthcare launched Clinic B t%li%support and help patients with comprehensive and advanced treatment for all types of breast health problems - ranging from benign lumps and cysts t%li%tumors and reconstruction.
Furthermore, immunotherapy has become an important part of treating some types of cancer in recent years. Immunotherapy is an advanced type of treatment that is growing its presence due t%li%its ability t%li%enhance the immune system's ability t%li%fight cancer by directing it toward cancer-specific targets; this leads t%li%growing strategic initiatives by the service providers t%li%grow its presence in the market, which is expected t%li%drive the growth in the coming years. In January 2023, BioNTech SE collaborated with the UK government t%li%provide clinical trials for modified mRNA immunotherapies for up t%li%10,000 patients by the end of 2030. In addition, it is focused on offering infectious disease vaccines and investment t%li%increase its footprint in the UK market.
Furthermore, several industry players are launching new services t%li%improve their penetration. For instance, in March 2024, Tampa General Hospital commenced the TGH Cancer Institute Phase I Cancer Research Unit at the main campus in Tampa. The aim of this Phase I Cancer Research Unit is t%li%provide cancer patients with access t%li%leading-edge research studies integrated with compassionate and comprehensive care.
Cancer Treatment Facilities Market Report Highlights
- In terms of treatment, the cancer surgery segment dominated the market with a revenue share of 34.12% in 2023. The development and increasing adoption of robotic surgery techniques is having a significant impact on the growth of the segment. However, chemotherapy services are the fastest-growing segment during the forecast period.
- Based on the cancer type, the blood cancer segment accounted for the maximum revenue share in 2023. This growth is attributed t%li%the increasing involvement of key companies in the R&D of blood cancer treatments globally.
- Based on provider, the hospital segment accounted for the maximum revenue share in 2023 due t%li%its advanced diagnostic and treatment capabilities in oncology departments.
- Asia Pacific dominated the market in 2023 due t%li%factors such as the growing cancer incidence, increasing demand for personalized care, and the rise in the development of healthcare infrastructure.
- In May 2024, HCG (Healthcare Global Enterprises) opened new cancer care centers in North Bengaluru, adding a total of 125 beds. These strategically positioned facilities will provide a complete range of advanced cancer treatments, from diagnosis t%li%personalized treatment plans.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Treatment
1.2.2. Cancer Type
1.2.3. Provider
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Volume Price Analysis
1.9. List of Secondary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
CHAPTER 3. MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing incidence of cancers
3.2.1.2. Technology advancement
3.2.1.3. Rising medical tourism
3.2.1.4. Growing government investment in cancer treatment facility
3.2.2. Market Restraint Analysis
3.2.2.1. High initial investment cost to setup cancer treatment facility
3.2.2.2. Stringent regulations for cancer treatment facility setup
3.3. Business Environment Analysis
3.3.1. Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
CHAPTER 4. CANCER TREATMENT FACILITIES MARKET: TREATMENT ESTIMATES & TREND ANALYSIS
4.1. Treatment Market Share, 2023 & 2030
4.2. Treatment Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Treatment, 2018 to 2030 (USD Million)
4.4. Bone Marrow Transplantation
4.4.1. Bone marrow transplantation market estimates and forecasts, 2018 - 2030 (USD Million)
4.5. Chemotherapy
4.5.1. Chemotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
4.6. Radiation Therapy
4.6.1. Radiation therapy market estimates and forecasts, 2018 - 2030 (USD Million)
4.7. Hormone Therapy
4.7.1. Hormone therapy market estimates and forecasts, 2018 - 2030 (USD Million)
4.8. Immunotherapy
4.8.1. Immunotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
4.9. Cancer Surgery
4.9.1. Cancer surgery market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. CANCER TREATMENT FACILITIES MARKET: CANCER TYPE ESTIMATES & TREND ANALYSIS
5.1. Cancer Type Market Share, 2023 & 2030
5.2. Cancer Type Segment Dashboard
5.3. Market Size & Forecasts and Trend Analyses, by Cancer type, 2018 to 2030 (USD Million)
5.4. Blood Cancer
5.4.1. Blood cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.5. Breast Cancer
5.5.1. Breast cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.6. Prostate Cancer
5.6.1. Prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.7. Gastrointestinal Cancer
5.7.1. Gastrointestinal cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.8. Gynecologic Cancer
5.8.1. Gynecologic cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.9. Respiratory/Lung Cancer
5.9.1. Respiratory/Lung cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.10. Other Cancer Types
5.10.1. Other cancer types market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. CANCER TREATMENT FACILITIES MARKET: PROVIDER ESTIMATES & TREND ANALYSIS
6.1. Provider Market Share, 2023 & 2030
6.2. Provider Segment Dashboard
6.3. Market Size & Forecasts and Trend Analyses, by Provider, 2018 to 2030 (USD Million)
6.4. Cancer Centers
6.4.1. Cancer centers market estimates and forecasts, 2018 - 2030 (USD Million)
6.5. Hospitals
6.5.1. Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. CANCER TREATMENT FACILITIES MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030
7.4. North America
7.4.1. North America cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.2. U.S.
7.4.2.1. Key country dynamic
7.4.2.2. Regulatory framework
7.4.2.3. Competitive insights
7.4.2.4. U.S. cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.3. Canada
7.4.3.1. Key country dynamic
7.4.3.2. Regulatory framework
7.4.3.3. Competitive insights
7.4.3.4. Canada cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.4. Mexico
7.4.4.1. Key country dynamic
7.4.4.2. Regulatory framework
7.4.4.3. Competitive insights
7.4.4.4. Mexico cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.5. Europe
7.5.1. Europe cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.2. Germany
7.5.2.1. Key country dynamic
7.5.2.2. Regulatory framework
7.5.2.3. Competitive insights
7.5.2.4. Germany cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.3. UK
7.5.3.1. Key country dynamic
7.5.3.2. Regulatory framework
7.5.3.3. Competitive insights
7.5.3.4. UK cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.4. France
7.5.4.1. Key country dynamic
7.5.4.2. Regulatory framework
7.5.4.3. Competitive insights
7.5.4.4. France cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.5. Italy
7.5.5.1. Key country dynamic
7.5.5.2. Regulatory framework
7.5.5.3. Competitive insights
7.5.5.4. Italy cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.6. Spain
7.5.6.1. Key country dynamic
7.5.6.2. Regulatory framework
7.5.6.3. Competitive insights
7.5.6.4. Spain cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.7. Denmark
7.5.7.1. Key country dynamic
7.5.7.2. Regulatory framework
7.5.7.3. Competitive insights
7.5.7.4. Denmark cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.8. Sweden
7.5.8.1. Key country dynamic
7.5.8.2. Regulatory framework
7.5.8.3. Competitive insights
7.5.8.4. Sweden cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.9. Norway
7.5.9.1. Key country dynamic
7.5.9.2. Regulatory framework
7.5.9.3. Competitive insights
7.5.9.4. Norway cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.2. Japan
7.6.2.1. Key country dynamic
7.6.2.2. Regulatory framework
7.6.2.3. Competitive insights
7.6.2.4. Japan cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.3. China
7.6.3.1. Key country dynamic
7.6.3.2. Regulatory framework
7.6.3.3. Competitive insights
7.6.3.4. China cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.4. India
7.6.4.1. Key country dynamic
7.6.4.2. Regulatory framework
7.6.4.3. Competitive insights
7.6.4.4. India cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.5. South Korea
7.6.5.1. Key country dynamic
7.6.5.2. Regulatory framework
7.6.5.3. Competitive insights
7.6.5.4. South Korea cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.6. Australia
7.6.6.1. Key country dynamic
7.6.6.2. Regulatory framework
7.6.6.3. Competitive insights
7.6.6.4. Australia cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.7. Thailand
7.6.7.1. Key country dynamic
7.6.7.2. Regulatory framework
7.6.7.3. Competitive insights
7.6.7.4. Thailand cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.7. Latin America
7.7.1. Latin America cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key country dynamic
7.7.2.2. Regulatory framework
7.7.2.3. Competitive insights
7.7.2.4. Brazil cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key country dynamic
7.7.3.2. Regulatory framework
7.7.3.3. Competitive insights
7.7.3.4. Argentina cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.8. MEA
7.8.1. MEA cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key country dynamic
7.8.2.2. Regulatory framework
7.8.2.3. Competitive insights
7.8.2.4. South Africa cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key country dynamic
7.8.3.2. Regulatory framework
7.8.3.3. Competitive insights
7.8.3.4. Saudi Arabia cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key country dynamic
7.8.4.2. Regulatory framework
7.8.4.3. Competitive insights
7.8.4.4. UAE cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key country dynamic
7.8.5.2. Regulatory framework
7.8.5.3. Competitive insights
7.8.5.4. Kuwait cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
8.5.1. Compass Oncology
8.5.1.1. Overview
8.5.1.2. Financial performance
8.5.1.3. Service benchmarking
8.5.1.4. Strategic initiatives
8.5.2. American Oncology Institute
8.5.2.1. Overview
8.5.2.2. Financial performance
8.5.2.3. Service benchmarking
8.5.2.4. Strategic initiatives
8.5.3. Mayo Foundation for Medical Education and Research (MFMER)
8.5.3.1. Overview
8.5.3.2. Financial performance
8.5.3.3. Service benchmarking
8.5.3.4. Strategic initiatives
8.5.4. HCA International Limited
8.5.4.1. Overview
8.5.4.2. Financial performance
8.5.4.3. Service benchmarking
8.5.4.4. Strategic initiatives
8.5.5. The Royal Marsden
8.5.5.1. Overview
8.5.5.2. Financial performance
8.5.5.3. Service benchmarking
8.5.5.4. Strategic initiatives
8.5.6. National Cancer Instituteat the National Institutes of Health
8.5.6.1. Overview
8.5.6.2. Financial performance
8.5.6.3. Service benchmarking
8.5.6.4. Strategic initiatives
8.5.7. Apollo Hospitals Enterprise Ltd.
8.5.7.1. Overview
8.5.7.2. Financial performance
8.5.7.3. Service benchmarking
8.5.7.4. Strategic initiatives
8.5.8. Kokilaben Dhirubhai Ambani Hospital
8.5.8.1. Overview
8.5.8.2. Financial performance
8.5.8.3. Service benchmarking
8.5.8.4. Strategic initiatives
8.5.9. HEALTHCARE GLOBAL ENTERPRISES LIMITED
8.5.9.1. Overview
8.5.9.2. Financial performance
8.5.9.3. Service benchmarking
8.5.9.4. Strategic initiatives
8.5.10. The Johns Hopkins Hospital
8.5.10.1. Overview
8.5.10.2. Financial performance
8.5.10.3. Service benchmarking
8.5.10.4. Strategic initiatives
8.5.11. Tata Memorial Centre.
8.5.11.1. Overview
8.5.11.2. Financial performance
8.5.11.3. Service benchmarking
8.5.11.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Treatment
1.2.2. Cancer Type
1.2.3. Provider
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Volume Price Analysis
1.9. List of Secondary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
CHAPTER 3. MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing incidence of cancers
3.2.1.2. Technology advancement
3.2.1.3. Rising medical tourism
3.2.1.4. Growing government investment in cancer treatment facility
3.2.2. Market Restraint Analysis
3.2.2.1. High initial investment cost to setup cancer treatment facility
3.2.2.2. Stringent regulations for cancer treatment facility setup
3.3. Business Environment Analysis
3.3.1. Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
CHAPTER 4. CANCER TREATMENT FACILITIES MARKET: TREATMENT ESTIMATES & TREND ANALYSIS
4.1. Treatment Market Share, 2023 & 2030
4.2. Treatment Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Treatment, 2018 to 2030 (USD Million)
4.4. Bone Marrow Transplantation
4.4.1. Bone marrow transplantation market estimates and forecasts, 2018 - 2030 (USD Million)
4.5. Chemotherapy
4.5.1. Chemotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
4.6. Radiation Therapy
4.6.1. Radiation therapy market estimates and forecasts, 2018 - 2030 (USD Million)
4.7. Hormone Therapy
4.7.1. Hormone therapy market estimates and forecasts, 2018 - 2030 (USD Million)
4.8. Immunotherapy
4.8.1. Immunotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
4.9. Cancer Surgery
4.9.1. Cancer surgery market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. CANCER TREATMENT FACILITIES MARKET: CANCER TYPE ESTIMATES & TREND ANALYSIS
5.1. Cancer Type Market Share, 2023 & 2030
5.2. Cancer Type Segment Dashboard
5.3. Market Size & Forecasts and Trend Analyses, by Cancer type, 2018 to 2030 (USD Million)
5.4. Blood Cancer
5.4.1. Blood cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.5. Breast Cancer
5.5.1. Breast cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.6. Prostate Cancer
5.6.1. Prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.7. Gastrointestinal Cancer
5.7.1. Gastrointestinal cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.8. Gynecologic Cancer
5.8.1. Gynecologic cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.9. Respiratory/Lung Cancer
5.9.1. Respiratory/Lung cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.10. Other Cancer Types
5.10.1. Other cancer types market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. CANCER TREATMENT FACILITIES MARKET: PROVIDER ESTIMATES & TREND ANALYSIS
6.1. Provider Market Share, 2023 & 2030
6.2. Provider Segment Dashboard
6.3. Market Size & Forecasts and Trend Analyses, by Provider, 2018 to 2030 (USD Million)
6.4. Cancer Centers
6.4.1. Cancer centers market estimates and forecasts, 2018 - 2030 (USD Million)
6.5. Hospitals
6.5.1. Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. CANCER TREATMENT FACILITIES MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030
7.4. North America
7.4.1. North America cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.2. U.S.
7.4.2.1. Key country dynamic
7.4.2.2. Regulatory framework
7.4.2.3. Competitive insights
7.4.2.4. U.S. cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.3. Canada
7.4.3.1. Key country dynamic
7.4.3.2. Regulatory framework
7.4.3.3. Competitive insights
7.4.3.4. Canada cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.4. Mexico
7.4.4.1. Key country dynamic
7.4.4.2. Regulatory framework
7.4.4.3. Competitive insights
7.4.4.4. Mexico cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.5. Europe
7.5.1. Europe cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.2. Germany
7.5.2.1. Key country dynamic
7.5.2.2. Regulatory framework
7.5.2.3. Competitive insights
7.5.2.4. Germany cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.3. UK
7.5.3.1. Key country dynamic
7.5.3.2. Regulatory framework
7.5.3.3. Competitive insights
7.5.3.4. UK cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.4. France
7.5.4.1. Key country dynamic
7.5.4.2. Regulatory framework
7.5.4.3. Competitive insights
7.5.4.4. France cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.5. Italy
7.5.5.1. Key country dynamic
7.5.5.2. Regulatory framework
7.5.5.3. Competitive insights
7.5.5.4. Italy cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.6. Spain
7.5.6.1. Key country dynamic
7.5.6.2. Regulatory framework
7.5.6.3. Competitive insights
7.5.6.4. Spain cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.7. Denmark
7.5.7.1. Key country dynamic
7.5.7.2. Regulatory framework
7.5.7.3. Competitive insights
7.5.7.4. Denmark cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.8. Sweden
7.5.8.1. Key country dynamic
7.5.8.2. Regulatory framework
7.5.8.3. Competitive insights
7.5.8.4. Sweden cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.9. Norway
7.5.9.1. Key country dynamic
7.5.9.2. Regulatory framework
7.5.9.3. Competitive insights
7.5.9.4. Norway cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.2. Japan
7.6.2.1. Key country dynamic
7.6.2.2. Regulatory framework
7.6.2.3. Competitive insights
7.6.2.4. Japan cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.3. China
7.6.3.1. Key country dynamic
7.6.3.2. Regulatory framework
7.6.3.3. Competitive insights
7.6.3.4. China cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.4. India
7.6.4.1. Key country dynamic
7.6.4.2. Regulatory framework
7.6.4.3. Competitive insights
7.6.4.4. India cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.5. South Korea
7.6.5.1. Key country dynamic
7.6.5.2. Regulatory framework
7.6.5.3. Competitive insights
7.6.5.4. South Korea cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.6. Australia
7.6.6.1. Key country dynamic
7.6.6.2. Regulatory framework
7.6.6.3. Competitive insights
7.6.6.4. Australia cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.7. Thailand
7.6.7.1. Key country dynamic
7.6.7.2. Regulatory framework
7.6.7.3. Competitive insights
7.6.7.4. Thailand cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.7. Latin America
7.7.1. Latin America cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key country dynamic
7.7.2.2. Regulatory framework
7.7.2.3. Competitive insights
7.7.2.4. Brazil cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key country dynamic
7.7.3.2. Regulatory framework
7.7.3.3. Competitive insights
7.7.3.4. Argentina cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.8. MEA
7.8.1. MEA cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key country dynamic
7.8.2.2. Regulatory framework
7.8.2.3. Competitive insights
7.8.2.4. South Africa cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key country dynamic
7.8.3.2. Regulatory framework
7.8.3.3. Competitive insights
7.8.3.4. Saudi Arabia cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key country dynamic
7.8.4.2. Regulatory framework
7.8.4.3. Competitive insights
7.8.4.4. UAE cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key country dynamic
7.8.5.2. Regulatory framework
7.8.5.3. Competitive insights
7.8.5.4. Kuwait cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
8.5.1. Compass Oncology
8.5.1.1. Overview
8.5.1.2. Financial performance
8.5.1.3. Service benchmarking
8.5.1.4. Strategic initiatives
8.5.2. American Oncology Institute
8.5.2.1. Overview
8.5.2.2. Financial performance
8.5.2.3. Service benchmarking
8.5.2.4. Strategic initiatives
8.5.3. Mayo Foundation for Medical Education and Research (MFMER)
8.5.3.1. Overview
8.5.3.2. Financial performance
8.5.3.3. Service benchmarking
8.5.3.4. Strategic initiatives
8.5.4. HCA International Limited
8.5.4.1. Overview
8.5.4.2. Financial performance
8.5.4.3. Service benchmarking
8.5.4.4. Strategic initiatives
8.5.5. The Royal Marsden
8.5.5.1. Overview
8.5.5.2. Financial performance
8.5.5.3. Service benchmarking
8.5.5.4. Strategic initiatives
8.5.6. National Cancer Instituteat the National Institutes of Health
8.5.6.1. Overview
8.5.6.2. Financial performance
8.5.6.3. Service benchmarking
8.5.6.4. Strategic initiatives
8.5.7. Apollo Hospitals Enterprise Ltd.
8.5.7.1. Overview
8.5.7.2. Financial performance
8.5.7.3. Service benchmarking
8.5.7.4. Strategic initiatives
8.5.8. Kokilaben Dhirubhai Ambani Hospital
8.5.8.1. Overview
8.5.8.2. Financial performance
8.5.8.3. Service benchmarking
8.5.8.4. Strategic initiatives
8.5.9. HEALTHCARE GLOBAL ENTERPRISES LIMITED
8.5.9.1. Overview
8.5.9.2. Financial performance
8.5.9.3. Service benchmarking
8.5.9.4. Strategic initiatives
8.5.10. The Johns Hopkins Hospital
8.5.10.1. Overview
8.5.10.2. Financial performance
8.5.10.3. Service benchmarking
8.5.10.4. Strategic initiatives
8.5.11. Tata Memorial Centre.
8.5.11.1. Overview
8.5.11.2. Financial performance
8.5.11.3. Service benchmarking
8.5.11.4. Strategic initiatives
LIST OF TABLES
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 4 Global cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 5 Global cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 6 Global cancer treatment facilities market, by region, 2018 - 2030 (USD Million)
Table 7 North America cancer treatment facilities market, by country, 2018 - 2030 (USD Million)
Table 8 North America cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 9 North America cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 10 North America cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 11 U.S. cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 12 U.S. cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 13 U.S. cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 14 Canada cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 15 Canada cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 16 Canada cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 17 Mexico cancer treatment facilities market, by teatment, 2018 - 2030 (USD Million)
Table 18 Mexico cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 19 Mexico cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 20 Europe cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 21 Europe cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 22 Europe cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 23 UK cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 24 UK cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 25 UK cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 26 Germany cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 27 Germany cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 28 Germany cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 29 France cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 30 France cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 31 France cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 32 Italy cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 33 Italy cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 34 Italy cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 35 Spain cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 36 Spain cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 37 Spain cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 38 Norway cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 39 Norway cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 40 Norway cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 41 Sweden cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 42 Sweden cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 43 Sweden cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 44 Denmark cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 45 Denmark cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 46 Denmark cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 47 Asia Pacific cancer treatment facilities market, by country, 2018 - 2030 (USD Million)
Table 48 Asia Pacific cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 49 Asia Pacific cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 50 Asia Pacific cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 51 Japan cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 52 Japan cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 53 Japan cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 54 China cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 55 China cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 56 China cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 57 India cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 58 India cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 59 India cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 60 Australia cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 61 Australia cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 62 Australia cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 63 South Korea cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 64 South Korea cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 65 South Korea cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 66 Thailand cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 67 Thailand cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 68 Thailand cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 69 Latin America cancer treatment facilities market, by country, 2018 - 2030 (USD Million)
Table 70 Latin America cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 71 Latin America cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 72 Latin America cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 73 Brazil cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 74 Brazil cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 75 Brazil cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 76 Argentina cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 77 Argentina cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 78 Argentina cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 79 Middle East & Africa cancer treatment facilities market, by country, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 83 South Africa cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 84 South Africa cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 85 South Africa cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 89 UAE cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 90 UAE cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 91 UAE cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 92 Kuwait cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 93 Kuwait cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 94 Kuwait cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 4 Global cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 5 Global cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 6 Global cancer treatment facilities market, by region, 2018 - 2030 (USD Million)
Table 7 North America cancer treatment facilities market, by country, 2018 - 2030 (USD Million)
Table 8 North America cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 9 North America cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 10 North America cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 11 U.S. cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 12 U.S. cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 13 U.S. cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 14 Canada cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 15 Canada cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 16 Canada cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 17 Mexico cancer treatment facilities market, by teatment, 2018 - 2030 (USD Million)
Table 18 Mexico cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 19 Mexico cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 20 Europe cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 21 Europe cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 22 Europe cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 23 UK cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 24 UK cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 25 UK cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 26 Germany cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 27 Germany cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 28 Germany cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 29 France cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 30 France cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 31 France cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 32 Italy cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 33 Italy cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 34 Italy cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 35 Spain cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 36 Spain cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 37 Spain cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 38 Norway cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 39 Norway cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 40 Norway cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 41 Sweden cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 42 Sweden cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 43 Sweden cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 44 Denmark cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 45 Denmark cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 46 Denmark cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 47 Asia Pacific cancer treatment facilities market, by country, 2018 - 2030 (USD Million)
Table 48 Asia Pacific cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 49 Asia Pacific cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 50 Asia Pacific cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 51 Japan cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 52 Japan cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 53 Japan cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 54 China cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 55 China cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 56 China cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 57 India cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 58 India cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 59 India cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 60 Australia cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 61 Australia cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 62 Australia cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 63 South Korea cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 64 South Korea cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 65 South Korea cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 66 Thailand cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 67 Thailand cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 68 Thailand cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 69 Latin America cancer treatment facilities market, by country, 2018 - 2030 (USD Million)
Table 70 Latin America cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 71 Latin America cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 72 Latin America cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 73 Brazil cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 74 Brazil cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 75 Brazil cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 76 Argentina cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 77 Argentina cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 78 Argentina cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 79 Middle East & Africa cancer treatment facilities market, by country, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 83 South Africa cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 84 South Africa cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 85 South Africa cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 89 UAE cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 90 UAE cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 91 UAE cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
Table 92 Kuwait cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
Table 93 Kuwait cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
Table 94 Kuwait cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Information Procurement
Fig. 2 Primary Research Patter
Fig. 3 Primary Research Process
Fig. 4 Market Research Approaches - Bottom-Up Approach
Fig. 5 Market Research Approaches - Top-Down Approach
Fig. 6 Market Research Approaches - Combined Approach
Fig. 7 Exterior insulation and finish system Market Segmentation
Fig. 8 Market Outlook
Fig. 9 Segmental Outlook
Fig. 10 Segmental Outlook
Fig. 11 Competitive Outlook
Fig. 12 Market Value Chain Analysis
Fig. 13 Market Dynamics
Fig. 14 Market Driver Impact Analysis
Fig. 15 Market Restraint Impact Analysis
Fig. 16 Industry Analysis - PORTERS
Fig. 17 Industry Analysis - PESTEL
Fig. 18 Type: Key Takeaways
Fig. 19 Type: Market Share, 2023 & 2030
Fig. 20 Insulation Material: Key Takeaways
Fig. 21 Insulation Material: Market Share, 2023 & 2030
Fig. 22 End Use: Key Takeaways
Fig. 23 End Use: Market Share, 2023 & 2030
Fig. 24 Competition Categorization
Fig. 25 Company Market Positioning
Fig. 26 Strategy Mapping, 2023
Fig. 1 Information Procurement
Fig. 2 Primary Research Patter
Fig. 3 Primary Research Process
Fig. 4 Market Research Approaches - Bottom-Up Approach
Fig. 5 Market Research Approaches - Top-Down Approach
Fig. 6 Market Research Approaches - Combined Approach
Fig. 7 Exterior insulation and finish system Market Segmentation
Fig. 8 Market Outlook
Fig. 9 Segmental Outlook
Fig. 10 Segmental Outlook
Fig. 11 Competitive Outlook
Fig. 12 Market Value Chain Analysis
Fig. 13 Market Dynamics
Fig. 14 Market Driver Impact Analysis
Fig. 15 Market Restraint Impact Analysis
Fig. 16 Industry Analysis - PORTERS
Fig. 17 Industry Analysis - PESTEL
Fig. 18 Type: Key Takeaways
Fig. 19 Type: Market Share, 2023 & 2030
Fig. 20 Insulation Material: Key Takeaways
Fig. 21 Insulation Material: Market Share, 2023 & 2030
Fig. 22 End Use: Key Takeaways
Fig. 23 End Use: Market Share, 2023 & 2030
Fig. 24 Competition Categorization
Fig. 25 Company Market Positioning
Fig. 26 Strategy Mapping, 2023
